Abstract. Current models propose that in nonpolarized cells, transport of plasma membrane proteins to the surface occurs by default. In contrast, compelling evidence indicates that in polarized epithelial cells, plasma membrane proteins are sorted in the TGN into at least two vectorial routes to apical and basolateral surface domains. Since both apical and basolateral proteins are also normally expressed by both polarized and nonpolarized cells, we explored here whether recently described basolateral sorting signals in the cytoplasmic domain of basolateral proteins are recognized and used for post-TGN transport by nonpolarized cells. To this end, we compared the inhibitory effect of basolateral signal peptides on the cytosol-stimulated release of two basolateral and one apical marker in semi-intact fibroblasts (3T3), pituitary (GH3), and epithelial (MDCK) cells. A basolateral signal peptide (VSVGp) corresponding to the 29-amino acid cytoplasmic tail of vesicular stomatitis virus G protein (VSVG) inhibited with identical potency the vesicular release of VSVG from the TGN of all three cell lines. On the other hand, the VSVG peptide did not inhibit the vesicular release of HA in MDCK cells nor of two polypeptide hormones (growth hormone and prolactin) in GH3 cells, whereas in 3T3 cells (influenza) hemagglutinin was inhibited, albeit with a 3 x lower potency than VSVG. The results support the existence of a basolateral-like, signal-mediated constitutive pathway from TGN to plasma mem-, brane in all three cell types, and suggest that an apicallike pathway may be present in fibroblasts. The data support cargo protein involvement, not bulk flow, in the formation of post-TGN vesicles and predict the involvement of distinct cytosolic factors in the assembly of apical and basolateral transport vesicles.
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T HE TGN, a tubular trans-Golgi compartment (Griffiths and Simons, 1986) , is the major sorting center of the secretory pathway (Griffiths et al., 1988) . At the TGN, lysosomal hydrolases are sorted into clathrincoated vesicles via mannose-6-phosphate receptors (Ludwig et al., 1995) , and secretory proteins are directed into distinct populations of constitutive secretory vesicles and immature regulated secretory granules by specific sorting signals (Griffiths and Simons, 1986; Tooze and Huttner, 1990; Melancon et al., 1991) . Early models postulated that plasma membrane proteins do not possess sorting signals and therefore enter by bulk flow post-TGN vesicles that transport and deliver them to the cell surface (Wieland et al., 1987 teins influenza hemagglutinin (HA) 1 and vesicular stomatitis virus G (VSVG) proteins in MDCK cells have identified two post-TGN routes to the cell surface mediated by distinct populations of transport vesicles (Rindler et al., 1984; Wandinger-Ness et al., 1990; Rodriguez-Boulan and Powell, 1992) . The existence of two post-TGN routes in epithelial cells implies that at least one of them is not a signal-blind default pathway and, indeed, transport signals have been recently identified in the cytoplasmic domain of basolateral proteins (Brewer and Roth, 1991; Hunziker et al., 1991; Le Bivic et al., 1991; Matter et al., 1992; Thomas et al., 1993) . Basolateral sorting signals resemble endocytic motifs of plasma membrane receptors; thus, by analogy with the assembly of clathrin-coated vesicles, they may interact with cytosolic coat proteins that mediate the incorporation of basolateral proteins into basolateral transport vesicles (Matter and Mellman, 1994) .
In neuroendocrine cells, the basolateral protein ~VSVG is transported via constitutively secreted vesicles to the cell surface (Green and Shields, 1984) . Exocytosis studies with chimeras of VSVG and regulated secreted proteins have shown that information for storage of regulated secretory proteins is present in the regulated secreted proteins (Moore and Kelly, 1985) . It has been suggested that these sorting signals mediate packaging of proteins into immature granules by interaction with a TGN-sorting receptor (Chung et al., 1989) , whereas proteins lacking appropriate signals are released via constitutive secretion by default (Moore and Kelly, 1985; Stoller and Shields, 1989) . A more recent alternative hypothesis postulates that the sorting signals in regulated secretory proteins promote the formation of specific protein aggregates that exclude constitutive proteins (Chanat and Huttner, 1992) . The latter are actively removed from extensions of the TGN destined to become secretory granules and from the immature granules themselves (Bauernfeind and Huttner, 1993) . Evidence in support of this model is provided by kinetic studies of regulated insulin secretion in isolated pancreatic islets (Kuliawat and Arvan, 1994) , by the high biochemical similarity of immature granules, condensing vesicles, and the TGN (Arvan and Castle, 1992) , and by the observation of clathrin coats in immature and condensing granules (Tooze and Tooze, 1986; Orci et al., 1987b) . As with epithelial cells, it is basic to determine whether the segregation of basolateral membrane proteins in constitutive secreting vesicles occurs by default or requires cytoplasmic sorting signals.
The observations summarized above raise fundamental questions regarding the transport of plasma membrane proteins to the cell surface of polarized and nonpolarized cells. In nonpolarized cells (a) are apical and basolateral proteins transported by separate post-TGN transport vesicles or by bulk flow via a single transport vesicle? (b) do basolateral proteins use basolateral signals and mechanisms, as in polarized MDCK cells? And in polarized cells (c) are basolateral signals involved in just the sorting of basolateral proteins into nascent vesicles or do they play an active role in the assembly of the vesicle?
To study the assembly of post-TGN vesicles in polarized and nonpolarized cells, we developed an in vitro assay that measures the cytosol-dependent release of apical, basolateral, and regulated secretory proteins from the TGN of semi-intact cells. The following cell lines were used: (a) MDCK, a polarized canine kidney line; (b) GH3, a rat anterior pituitary line synthesizing growth hormone (GH) and prolactin (Prl); and (c) 3T3, a mouse fibroblast line. To identify the characteristic basolateral route in polarized and nonpolarized cells, we studied the ability of basolateral signal peptides to compete with basolateral vesicle release. This approach is based on a recent observation by Pimplikar (1994) , who showed that introduction of the 29-amino acid cytoplasmic tail of VSVG protein into perforated MDCK cells specifically blocked transport of VSVG protein from the TGN to the cell surface but did not affect that of apical influenza HA, suggesting that the peptide competed with the VSVG protein tail for a basolateral transport factor in the cytosol. This result, however, was not generalized by using other basolateral signal peptides or proteins, raising the possibility that the inhibition might have been due to an effect that is specific for the sequence of the cytoplasmic domain of VSVG and unrelated to its basolateral sorting information. Here, we studied the effect of the VSVG peptide and four other basolateral signal peptides on the release of VSVG-, HA-, GH-, or Prl-containing vesicles in the three cell lines mentioned above. O,ur data suggest that (a) the constitutive pathway of VSVG protein in 3T3 fibroblasts and GH3 cells is identical to the basolateral route in MDCK cells; (b) at least two post-TGN pathways to the cell surface exist in all three cell lines; and (c) the release of post-TGN vesicles requires the recognition of signals in cargo molecules by the transport machinery and, therefore, does not occur by bulk flow.
Materials and Methods

Cells, Viruses
MDCK II cells, passages 6-20, were grown on 10-cm plastic dishes in DME + 5% FCS. 3T3 cells, obtained from th~ American Tissue Culture Collection (Rockville, MD), were grown in DME + 10% FCS.
GH3 cells, a rat anterior pituitary line that secretes GH and PrL were grown in Ham's F-10 containing 2.5% FCS and 12.5% horse serum as previously described (Stoller and Shields, 1988) .
Vesicular stomatitis virus, Indiana strain (VSV), and influenza virus A (WSN strain), were grown in MDCK cells as described (Rodriguez-Boulan and Sabatini, 1978) .
Infection and Pulse-Chase Labeling
For viral infection, GH3 cells were inoculated with 5-10 pfu/cell, MDCK and 3T3 cells with 50 pfu/cell of wild-type VSV (Indiana strain, a gift of Dr. P. Stanley, Albert Einstein College of Medicine Bronx, NY) for 1 h at 37°C, the cells were rinsed with PBS, and incubated a further 3.5 h before radiolabeling with [aSS]met (New England Nuclear, Boston, MA). Mockinfected and VSV-infected cells were pulse labeled with [35S]met for 10 min at 37°C followed by a chase incubation at 20°C for 2 h in the presence of 5-mM methonine and cysteine (MDCK, 3T3, GH3) and 20 l~g/ml cycloheximide (MDCK, 3T3) (Stoller and Shields, 1989) . MDCK and 3T3 cells were inoculated with 50 pfu/cell influenza WSN for 1 h at 37°C. Cells were then incubated for 4.5-h at 37°C and pulse labeled for 10 min with [35S]cys (New England Nuclear). The chase at 20°C resulted in ~60% of the labeled VSVG/HA proteins becoming Endoglycosidase H (Endo H) resistant (see Table I ). The Endo H-resistant population does not appear at the cell surface and was tested for accumulation in the TGN as described for the vesicle fractions in Fig. 1 
IlL Vesicle Budding from Semi-Intact Cells
Permeabilized GH3 cells from control and infected cells were prepared and incubated exactly as described (Xu and Shields, 1993) . The VSVG peptide (see Table II ) was added directly to the assay. Pellets and supernatants of the budding assay were extracted with Triton X-100 and VSVG was immunoprecipitated with a monoclonal antibody (5FctG, kindly provided by Dr. John Lewis, SUNY Health Science Center at Brooklyn, New York). GH and Prl were precipitated with polyclonal antibodies (Xu and Shields, 1993; Austen and Shields, 1996) as described previously (Xu and Shields, 1993) .
Semi-intact MDCK cells and 3T3 fibroblasts were prepared according to Beckers et al. (1987) and Xu and Shields (1993) after the reporter protein was accumulated in the TGN. In standard assays, semi-intact cells (20-25-p~g protein) were suspended in a final vol of 100 p.1 transport buffer (Xu and Shields, 1993) , supplemented with 60 or 120 p~g of gel-filtered brain cytosol (cone. 20 mg/ml) (prepared according to Malhotra et al., 1989 ; initially kindly provided by James Rothman, Memorial Sloan Kettering Institute, New York), and energy-regenerating mix (1 mM ATP, 0.12 mM GTP, 5 mM creatine phosphate, 0.2 IU creatine kinase) and incubated for 30 rain at 37°C. 120 p.g cytosol was used for the initial characterization of the vesicular budding of HA and VSVG (see Figs. 1, 2, and 3). After full characterization of the cytosol dependence of the budding assay (see Fig. 5 ), 60 ~g cytosol, the maximum concentration within the linear range, was chosen for all peptide experiments (except for Fig. 6, see legend) . After incubation, samples were centrifuged for 1 min at 15,000 g in a microfuge, after which nascent vesicles remain in the supernatant (Xu and Shields, 1993) . In the initial experiments in Fig. 1 , the sedimentation of the semiintact cells was performed by a 3-min spin at 800 g, conditions that gave similar results as the high-speed spin used for all later experiments. In standard assays, supernatant and pellet fractions were analyzed directly by PAGE, since viral proteins were the only labeled proteins under the infection conditions. In initial experiments (Figs. I and 2), VSVG and HA were immunoprecipitated after TX-100 solubilization with mAbs against the ectodomain (5FetG for VSVG, or H15-C5 hybridoma against HA, kindly provided by Dr. W. Gerhard, Wistar Institute, Philadelphia). For experiments involving immunoisolation of VSVG-containing vesicles on protein A-Sepharose beads (Fig. 1, H c and e) , the supernatant fraction of a budding reaction was first incubated in high salt buffer (0.4 M KCI, 20 mM Tris/HC1, pH 8.0, for 30 min on ice) to strip peripheral proteins on the vesicles; then the salt concentration was adjusted to 150 mM KCI and immunoprecipitation of VSVG was carried out with antibodies against the cytoplasmic domain (PD4; Kreis 1986) absorbed on protein A-Sepharose (Pbarmacia LKB Biotechnology Inc., Piscataway, N J).
A chimeric protein (TGG) constituted of the ectodomain of interleukin II receptor (Tac) and cytoplasmic and transmembrane domains of the TGN38, TGG, was immuneprecipitated from transfected MDCK cells (Rajasekaran et al., 1994 ) with a Tac mAb (7G7; Rubin et al., 1985) .
The sum of marker protein in the supernatant and pellet (S + P) fractions varied with a standard error of 3.6% (HA), 4.3% (VSVG), and 6.2% (TGG) of the total marker protein within a given experiment (see Table I for detailed analysis of this variation).
Mannosidase II was immunoprecipitated from supernatant and pellet fractions in the experiment shown in Fig. 2 after Triton X-100 solubilization using an antiserum raised against rat liver Golgi et-mannosidase II (Moremen et al., 1991) provided by Kelley Moremen, University of Georgia (Athens, GA).
For the experiments in Fig. 3 , 4-p~l anti-Gets (provided by Keith Mostov, University of California at San Francisco) were pre-incubated with 50 ~l cytosol for 1 h on ice. Cholera and Pertussis toxins were incubated according to Bomsel and Mostov (1993) . The energy mix contained additionally, 0.1 mM GDP.
Peptide Application
HPLC-purified (>95% purity) lyophilized peptides were dissolved in water immediately before use to prevent aggregation by oxidation or denaturation. The peptides were added directly to the budding assay; their concentration was measured by UV absorbance at 205 nm after experimental determination of their extinction coefficient with the formula E lmg/ml = 27 + 120 × A280/A205. It should be noted that the pH of the incubation mixture was not altered by the addition of these peptides. The cytosol concentration used for all peptide experiments (60 ~g) gave maximal stimulation of budding in the linear range. To determine the half-maximal inhibitory peptide concentration, the cytosol-dependent vesicle budding (after subtraction of the background budding without cytosol) in the presence of five (or four in 3T3 cells) different peptide concentrations was measured as released radioactivity in the supernatant fractions and expressed as percent of the control budding in the absence of peptide. The IC-50 values were calculated using a Cricket graph program from the slope of the linear plot of the reciprocal values of the budding (expressed as percent values) against the five peptide concentrations (Table III) . The lowest correlation coefficient accepted was R = 0.75; for most graphs the correlation coefficient varied between 0.85 and 0.95. The following peptide concentrations were tested: VSVGWTp: 10, 20, 50, 100, 150 p~M (for VSVG and TGG in MDCK cells); 10, 20, 50, 100, 200 ~, M (for HA in MDCK cells); 10, 20, 50, 150 p.M (in 3T3 cells) and 10, 20, 30, 100, 150 p~M (in GH3 cells); VSVGA19p: 20, 50, 100, 150, 200 ~M (in MDCK cells); 10, 20, 50, 150 ~M (in 3T3 cells) and 10, 20, 30, 100, 150 pLM (in GH3 cells) ; all other peptides: 50, 100, 150, 200, 300 p~M.
Digestion with Glycosidases
All digestions were performed after immunoprecipitation on protein A beads (13-galactosidase, neuraminidase) or after removing the sample from the beads by 2% SDS (Endo H) at 37°C in the presenceot a protease inhibitor cocktail. After digestion, the samples were TCA'precipitated and prepared for SDS-PAGE (Endo H) or digested protein was removed from the protein A-Sepharose beads by boiling in SDS gel sample buffer.
The following incubation conditions were used for the various enzymes. Endo H: 5 mU endo-13-N-acetylglucosaminidase H (Boehringer Mannheim Biochemicals, Indianapolis, IN) in 100 mM citrate buffer, pH 5.5, 0.1% SDS, for 8 h; [3-Galactosidase: 1 U of jack bean meal 13-galactosidase (Oxford GlycoSystems, Rosedale, NY) in 50 mM citrate buffer pH 3.5 3 × for 7 h; Neuraminidase: 5 mU Neuraminidase (Boehringer Mannheim Biochemicals) in 100 mM citrate buffer, pH 5.5, for 8 h.
Electrophoresis SDS-PAGE. All electrophoretic procedures were carried out in 10% polyacrylamide gels according to Laemmli 1970 , with the exception of the experiment shown in Fig. 1 , IIl e and f, carried out in 8-12% gradient gels with 12% glycerol. Fluorography was carried out after impregnation of the gels in 0.1 M sodium salicylate.
Isoelectric Focusing (IEF) . IEF analysis of VSVG was carried out in slab gels, 37 cm x 20 cm in size, composi[ion 4.7% T/0.5% C acrylamide/ bisacrylamide, 9.2 M urea, 2% NP-40, 1.2% ampholines, pH 5-7, 1.2% ampholines, pH 3.5-10, 0.17% ampholines, pH 7-10. The sample buffer contained 9.5% urea, 2% NP-40, 2% ampholines pH 3.5-10, 5% 13-mercaptoethanol. The running time was 16 h at constant power (3 W) with maximal voltage from initial 220 V to 750 V; fluorography was carried out after impregnation with DMSO/PPO.
Quantification of Bands in Fluorograms
Gels were exposed to x-ray film for doubling time periods and the films scanned with a Mirror Scanner 800 Plus (Mirror Technologies, Inc., St. Paul, MN). Data were evaluated by measuring the amount of gray in each band above the background with the Macintosh Image 1.45 program. For the supernatant and pellet fractions, different exposures were used to ensure that the bands were in the linear range of the gray scale which was estimated by coanalyzing a standard gel with doubling amounts of radioactivity per unit area.
Electron Microscopy
Supernatant fractions of a VSVG budding reaction were pelleted in an airfuge (A100/18 ° rotor; Beckman Instruments Inc., Fullerton, CA) at 20 psi; the pellet resuspended and directly applied to nickel grids. Grids were contrasted with 1.5% uranyl acetate and examined in an electron microscope (100 CX; JEOL USA Inc., Peabody, MA). VSVG-containing vesicles were immunoisolated on protein A-Sepharose beads as described above, fixed in 2.5% glutaraldehyde, 0.1% Na cacodylate, pH 7.4, processed for transmission EM as previously described (Rodriguez-Boulan and Sabatini, 1978) , and examined in a JEOL 100 CX electron microscope.
Results
Release of VSVG-and HA-containing Vesicles from the TGN of Permeabilized MDCK Cells
The strategy of this assay was to accumulate the basolateral reporter protein VSVG or the apical marker influenza HA protein in the TGN of MDCK cells using a reversible 20°C temperature block (Matlin and Simons, 1984) and then permeabilize the cells (Beckers et al., 1987) to study and manipulate the process of TGN-derived vesicle budding. Cells were pulse labeled for 10 min with [35S]methionine/cysteine and chased for 2 h at 20°C. Under these conditions, an average of 57.5% of the nascent HA and 60.5 % of VSVG accumulated in the TGN with the balance trapped in the ER and no radioactive viral protein was detectable at the cell surface. After the temperature block, permeabilized cells were prepared. We confirmed that the TGN remained intact during the preparation of semiintact cells as antibodies against the luminal domain of TGG, a chimeric TGN marker (Humphrey et al., 1993) , only stained the TGN in the presence of saponin (see temperature of 37°C. Semi-intact cells with either VSVG or HA protein accumulated in the TGN or uninfected cells expressing TGG were supplemented with gel filtrated brain cytosol and energy mix as indicated, and incubated for 30 min at 37, 20, or 0°C. The ceils were sedimented and the protein in the pellet (P) and the supernatant (S) was analyzed by immunoprecipitation and PAGE; 0.6 U/ml apyrase was added to the samples in lane 2 in the VSVG and HA panel and lane 6 in the TGG panel. (I/) The released proteins are contained in vesicles, a and b: The supernatant fraction was divided into three aliquots and proteinase K (0.5 mg/ml) or trypsin (0.5 mg/ml) and Triton X-100 (1%) were added as indicated; protease incubation occured for 30 min on ice and was inactivated by 1 mM PMSF or trypsin inhibitor, c: One-half of the supernatant was adjusted to 1% Triton X-100. One-half of both, the Triton-solubilized (lanes 2 and 4) and the nonsolubilized (lanes I and 3) fraction, was immunoprecipitated with antibodies against the ectodomain of VSVG (AB ecto; lanes I and 2); the other half of both fractions was immunoprecipitated with antibodies against the cytoplasmic tail of VSVG (AB tail; lanes 3 and 4). d: EM of negatively stained vesicles released in this assay. Bar in detail, 100 nm. e: Transmission EM of vesicles isolated with antibodies against the cytoplasmic domain of VSVG on protein A-Sepharose beads. Bar, 100 nm. (111) Vesicular VSVG and HA contain carbohydrate modifications of the late Golgi and TGN. The supernatant of a budding assay with VSVG (e and g) or HA (f) was immunoprecipitated and subjected to digestion with the glycosidases endo H, 13-glycosidase, or neuraminidase as indicated. Neuraminidase digestion with subsequent 13-galactosidase treatment was performed for sample 2 in e; separation of proteins occured by SDS-PAGE (e and/') or IEF (g); lanes I and 3 in fcontain 1/20 of sample that was loaded in lanes 2, 4, and 5; the arrowhead in lane 5 marks the position of the ER form of HA in the gel. 5). Furthermore, VSVG in the T G N of semi-intact cells was accessible to antibodies against the cytoplasmic domain of the protein but inaccessible to antibodies against its ectodomain (data not shown).
The addition of cytosol and an energy-regenerating system to high salt washed semi-intact cells resulted in an average of 21% of total VSVG and 27% of total H A protein (see Table I ) being released into nascent vesicles, (Fig. 1 I lanes 1 and 3) . In agreement with data on the formation of secretory vesicles (Xu and Shields, 1993) , no VSVG or HA release was observed if the budding reaction was performed at 0 or 20°C (lanes 4 and 5) and the release of both was decreased markedly if either cytosol or the energyregenerating system was absent (see Fig. 1 I lanes 2 and 6 and Table I ). The TGG chimera, which recycles efficiently between the TGN and the basolateral plasma membrane as does its endogenous counterpart TGN38 (Rajasekaran et al., 1994) , was also released in a cytosol-and temperature-dependent fashion (14% in the presence versus 3.5% in the absence of cytosol), after accumulation in the TGN in the presence of cycloheximide for 2 h at 20°C (see Fig. 1 I and Table I ).
Several experiments indicated that VSVG and HA were released into nascent vesicles (Fig. 1, H and III) . (a) Treatment with proteinase K removed only the cytoplasmic tail of the VSVG, visible as a slight increase in its electrophoretic mobility (Fig. 1, H a lanes I and 2) . That this represented protection, but not intrinsic protease insensitivity of the ectodomain, was shown by the addition of proteinase K together with 1% Triton X-100, which resulted in complete digestion of the protein (Fig 1. , H a, lane 3); (b) antibodies against the cytoplamic tail of VSVG precipitated the protein both with and without solubilization with Triton X-100 (Fig. 1 , H c, lanes 3 and 4; the amount in lane 3 is 70% of that in lane 4), whereas antibodies against the ectodomain of VSVG had access to their epitopes only when Triton X-100 was present in the immunoprecipitation reaction (Fig. 1 , H c, lanes 1 and 2; the amount of VSVG in lane I is only 18% of that in lane 2). Isolation of VSVG membrane structures from the supernatant fraction using protein A-Sepharose beads coated with antibodies against the cytoplasmic domain of the protein revealed a population of 60-90-nm vesicles on the surface of the beads by EM (Fig. 1, H e) . (c) HA has a single trypsin cleavage site in its ectodomain, giving raise to the forms HA1 (50 kD) and HA2 (25 kD). Addition of trypsin resulted in the generation of the two forms only in the presence of detergent (Fig. 1, H b) ; (d) the supernatant fraction of a vesicle budding assay showed a homogenous vesicle population, as determined by EM after negative staining (Fig. 1,//d) .
To determine the origin of the vesicles carrying VSVG and HA, we analyzed the posttranslational modifications characteristic of the Golgi or TGN, using specific glycosidases (Fig. 1 III) . VSVG protein (which possesses two complex carbohydrate side chains (Etchison et al., 1977) , released into the supernatant of permeabilized cells was completely resistant to Endo H treatment, indicating that the bulk of this protein had reached the medial-Golgi complex (Fig. 1 , III e, lane 4) (Tarantino et al., 1978) . Treatment with 13-galactosidase resulted in a visible shift of the VSVG upon SDS-PAGE only when a preceding neuraminidase digestion removed the terminal sialic acid residues and rendered 13-galactose the terminal residue of the complex sugars (Fig. 1 , III e, lanes 1, 2, and 3). Together with the dramatic anodic shift in the isoelectric point of VSVG protein upon neuraminidase treatment (Fig. 1, III g, lanes 1 and 2) , as a result of sialic acid removal, we can conclude that most of the VSVG protein had reached the TGN, the reported locale of sialyl transferases (Roth et al., 1985; Chege and Pfeffer, 1990) . The mature influenza WSN HA contains, in addition to two complex carbohydrate chains, a high mannose side chain (Roth et al., 1986) , and hence undergoes a large Endo H-induced electrophoretic mobility increase when it is in the ER, but only a slight mobility increase after arrival at the Golgi complex. Only a small fraction of the HA released in the supernatant underwent the large electrophoretic shift characteristic of the ER form, whereas most of the released HA was reduced only slightly in size after Endo H treatment (Fig. 1 , llIf, lane 5). Furthermore, HA also manifested a slight shift in electrophoretic mobility upon treatment with [3-galactosidase ( Fig. 1 , III f, lanes 1 and 2 versus 3 and 4). Because it coexists with viral neuraminidase in influenza-infected cells, HA is sensitive to 13-galactosidase without pretreatment with neuraminidase (not shown). These data indicated that the majority of the HA molecules had left the ER and reached at least the trans-Golgi cisternae, the postulated locale of galactosyl transferase (Kornfeld and Kornfeld, 1985) . The preceding results demonstrate that VSVG and HA released in vesicles in the TGN budding assay displayed carbohydrate modifications typical for the TGN (VSVG) or at least the late Golgi (HA). Interestingly, the population of viral glycoproteins that did not reach the TGN during the 20°C incubation period was not released efficiently The percentage of Endo H-resistant VSVG or HA protein (percent of marker in the TGN) was determined as described in Materials and Methods, after accumulation of the marker protein in the TGN by a 20°C block. The amount of each marker in the supematant (S) fraction (percent budded marker), released in the presence or absence of 60 p,g of cytosol, is expressed as a percent of the total (ER + Golgi) marker. To estimate the sample variation within individual experiments, the standard error of the sums P + S (SEI, ÷s) (where P is the amount of marker in the pellet and S is the amount of marker in the supematant) was calculated for each experiment (5-12 samples per experiment) and normalized as a percent of the total amount of marker in the sample. In this case, mean represents the average of the normalized SEp + s from n experiments. For example, in one of the HA experiments containing 10 samples, the values of the sums P + S were: 8, 500, 8, 780, 7, 370, 9, 010, 8, 660, 7, 980, 9, 270, 8, 370, 8, 800, 9 ,330 pixels; therefore the mean was 8,643 pixels; the SE e + s was 186.5; and the normalized SEa + s was 2.15%. cysteine for 15 h; they were then infected with VSV, pulse labeled, and chased at 20°C as described in Materials and Methods. A standard budding assay was performed as described in Materials and Methods. One-fifth of the supernatant and pellet fractions was immunoprecipitated with antibodies against VSVG (lanes 1, 2, 4, and 5) and four-fifths of each fraction with antibodies against mannosidase II (lanes 3 and 6). The mannosidase lanes were exposed twice as long to obtain exposures of comparable intensity to VSVG.
during the 37°C incubation in vitro, indicating that these molecules were trapped in the ER. Since an average of 21% of VSVG or 27% of HA, expressed as percent of total viral glycoprotein, was released in vesicles (Table I) , and 60.5% of VSVG, or 57.5% of HA, were in the TGN (see Table I ), the average vesicular release from the TGN in our standard budding assay was 35% for VSVG and 45% for HA. Although no radiolabeled protein reached the surface under the pulse-chase conditions, we excluded the possibility that VSVG-containing vesicles contained surface biotinylated plasma membrane markers (data not shown). This indicated that neither VSVG itself nor other vesicle components were derived from vesiculated plasma membrane fragments. We also excluded the possibility that VSVG was released into the supernatant fraction by artefactual fragmentation of the Golgi apparatus (Fig. 2) . Immunoprecipitation of the Golgi marker mannosidase II (labeled overnight with [35S]methionine/cysteine) from pellet and supernatant fractions obtained from a standard assay for VSVG release revealed undetectable levels of the enzyme under conditions where no new enzyme was produced due to host protein synthesis suppression by the virus. Since our assay did not allow us to determine directly if H A and VSVG protein were released into distinct apical and basolateral vesicles distinguished by their ability to fuse with the appropriate surface domains, we investigated pharmacologic features of TGN vesicle budding that may discriminate between HA-and VSVG-containing vesicles. Fig. 1/) were performed in the presence of 10 IxM Mastoparan, 100 p,g/ml Cholera or Pertussis toxins or anti-Gas serum or normal serum as described in Materials and Methods; budding as percentage of control samples was determined in three or four experiments. *, a significant difference for HA and VSVG (P ~< 0.05), determined by a paired t test. Pimplikar and Simons (1993) have suggested that different trimeric G proteins regulate transport of apical and basolateral proteins from the TGN to the cell surface with Gai being a negative regulator for basolateral transport and Gas a positive regulator of apical transport. We therefore determined if this regulation could occur at the level of vesicle release from the TGN. Cholera toxin, an activator of Gas, stimulated H A protein budding almost two-fold, whereas pertussis toxin, an inhibitor of Gai stimulated VSVG protein budding and slightly inhibited that of HA (Fig. 3) . Consistent with this observation, antibodies against Gas inhibited predominantly the release of the apical marker, and mastoparan, which is known to mimic receptors for Gai, inhibited release of the basolateral protein from the TGN (Fig. 3) . When expressed as percentage of controls, vesicular budding of VSVG and H A were significantly different from each other in the presence of mastoparan, cholera toxin, and Gas antibodies, suggesting that VSVG and H A are released into different vesicle types. The data further indicate that the regulation of TGN to surface transport of VSVG and H A by trimeric G proteins occurs at the level of vesicle release from the TGN, suggesting that Gai and Gas may interact with membrane proteins that are part of the basolateral and apical vesicle transport machinery at the TGN.
Effect of Peptides Possessing Basolateral Targeting Domains on the Budding of Basolateral and Apical Proteins from the TGN
If the cytoplasmic tails of basolaterally targeted proteins interact with cytosolic factors, it should be possible to interfere with this process by adding appropriate peptides to the in vitro budding assay. The peptides tested (VSVGp, 
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Irrelevant pepfide releasing peptide * Mostov et al., 1987; tCasanova et al., 1991; ~Nabi et al., 1991; IIRajasekaran et al., 1994; IThomas et al., 1993; **Brewer and Roth, 1991; *SMatter et al., 1992 ; bl = basolateral, ap = apical, PM = plasma membrane.
HAYp, TGN 38p, LEP100p, pIgRp) and the evidence for their basolateral sorting information is shown in Table II . Three arbitrarily chosen peptides (R1, R2, R3) and three peptides representing the entire cytoplasmic tail of apically targeted proteins (HAC, lgpl20C8, LDLCT12) served as controls for these experiments. The most potent inhibitor of VSVG vesicle budding was VSVGp, a peptide corresponding to the 29 cytoplasmic amino acids of VSVG, which contains a well-established basolateral signal (Thomas et al., 1993) . VSVGp inhibited budding of VSVG-containing vesicles at 25 I~M and caused almost complete inhibition at ,-~50 ~M (Fig. 4 A) . In contrast, a mutant peptide that fails to act as a basolateral signal in vivo (Thomas et al., 1993) , VSVGA19p, was approximately six times less efficient as an inhibitor in the in vitro assay (IC50 = 24 ~M vs. 143 ~M, respectively, Table III ). Furthermore, VSVGp was approximately six times less efficient in inhibiting the budding of influenza HA from the TGN of MDCK cells, indicating a strong preference for the basolateral mechanism (Fig. 4 A, VSVG vs. HA, top) . Since the mutant VSVGp had little effect on vesicle budding and the wild-type peptide had dramatically different effects on VSVG and HA release, this attested to the specificity of the budding of VSVG-containing vesicles from the TGN. To exclude further the posssibility that VSVGp did not cause disruption of the Golgi, we demonstrated that TGG remained inaccessible to antibodies in the presence of 50 ~.M VSVGp in semi-intact cells and that at the EM level, the appearance of Golgi stacks was not altered (Fig. 5) .
We considered the possibility that the inhibitory effect of VSVG peptide on the release of VSVG protein was due to identity between the peptide and the protein being transported. To exclude this possibility, we studied the effect of VSVGp on a second basolateral marker, TGG. VSVGp inhibited the budding of vesicles carrying TGG with an IC-50 ,,~43 IxM, even lower than the IC-50 of the homologous peptide TGN38p (see Table III and Fig. 4 A, TGG panel). Our data therefore demonstrate that the potent inhibitory effect of VSVGp on the release of basolateral vesicles in general reflects a functional property of the basolateral vesicle budding system. Two other peptides, HAYp and TGN38p, inhibited the budding of VSVG vesicles at higher concentrations (IC-50 ,'~115 and -,~83 ~M) than VSVGp. The control peptides (HAC, LDLCT12, R1, R2, R3), however, were ineffective at these concentrations (Tables II and III) . HACp, representing the cytoplasmic domain of wild-type HA, had a considerably reduced inhibitory potency compared with HAYp from which it differs only in a single amino acid. The inhibitory effect of the HAY peptide was dependent on the same tyrosine residues that are critical for basolateral targeting in vivo (Brewer and Roth, 1991; Thomas et al., 1993) . Therefore, HACp provides a strong argument for the validity of our assay as tool to characterize the basolateral sorting mechanism. Our results generalize previous observations by Pimplikar et al. (1994) showing that the VSVG peptide inhibits specifically not only the exit of VSVG protein from the TGN but also, and with high potency, the release of a second basolateral marker, TGG, and by demonstrating that other basolateral signal peptides (HAYp, TGN38p) inhibit the release of VSVG protein. As with VSVGp, the inhibitory effect of HAY was highly specific since the release of the basolateral marker was dependent on a crucial tyrosine residue necessary for basolateral targeting in vivo.
The inhibitory effect of the basolateral signal peptides may be due to their competition with a cytosolic factor for the binding to VSVG. If this were the case it should be possible to overcome the inhibitory effect of the peptides by increasing the amount of cytosol in the budding assay. Fig. 6 shows that this is the case for the VSVGp. Fig. 7 (left) indicates that the inhibitory effect of TGN38p and HAYp could also be overcome by increasing amounts of cytosol.
As mentioned above, VSVGp did not interfere with the budding of vesicles carrying HA at concentrations that completely blocked the budding of VSVG vesicles (Fig. 4  A) . This result favors our interpretation that VSVGp specifically interferes with the release of basolateral transport vesicles in polarized MDCK cells. On the other hand, the three peptides VSVGp, HAYp, and TGN38p inhibited the vesicular release of HA with IC-50's of N150 ~M. In contrast, the control peptide HAC had an effect on the vesicular release of HA only at a concentration of 300 IxM (Ta- Vesicle budding assays for VSG, TC~, or HA protein were performed in the absence or presence of the fisted pepfides. Vesicle budding in the presence of peptides was expressed as percentage of control budding in the assay without peptide and its reciprocal values were plotted against the peptide concentrations. The 50% inhibitory concentration and the standard deviation were calculated from the number of experiments indicated in brackets for each peptide as described in Materials and Methods. Figure 5 . The VSVG peptide does not disrupt Golgi structure. A standard budding assay was carried out with semi-intact MDCK cells permanently transfected with TGG in the presence or absence of 50 I~M VSVGp. Aliquots of the pellet fractions were fixed with 2% paraformaldehyde and processed for immunofluorescence with antibodies against the ectodomain of the TGN marker TGG (Tac) in the presence or absence of 0.075% saponin. The labeled semi-intact cells were spread on coverslips, mounted on glass slides, and analyzed by confocal microscopy. Another aliquot of the pellet was fixed in 2% glutaraldehyde, 0.1 M cacodylate buffer, pH 7.4, and processed for transmission EM. Note that the addition of the peptide did not increase the accessibility of the luminal Tac epitopes to antibodies nor abolished the stacked organization of the Golgi. ble III). The inhibitory effect of the three signal peptides was reduced in the presence of higher cytosol concentrations in the assay (Fig. 7, right) , suggesting that the effect of the peptides on the H A vesicle budding was due to a competition with soluble factors that are similar or identical with basolateral transport factors. Note that whereas 3 p~g/ml cytosol partially overcame the inhibition of H A release by 150 IxM VSVGp, it did not overcome the inhibition of VSVG release by 50 ~M VSVGp, a result that further underlines the differential inhibitory effect of VSVGp on basolateral vs. apical vesicle release.
Effect of VSVGp on the Budding of VSVG or HA Vesicles from the TGN in 3T3 Cells
Since the VSVG peptide allowed us to discriminate between the pathways for apical and basolateral vesicle release from the TGN in MDCK cells, this peptide was used to study whether VSVG protein and H A are released in a single vesicle type or in different vesicles from the TGN of nonpolarized fibroblasts. Permeabilized 3T3 cells with either VSVG or H A protein accumulated at the TGN were prepared. Omission of cytosol or the energy mix reduced the vesicular marker protein in the supernatant to 20% (Fig. 4 A, 3T3 panel, see lanes I and 2). VSVGp and VSVGA19p inhibited the budding of VSVG-containing vesicles with IC-50 ~20 and 134 ~M, respectively (Table  III, Fig. 4 A) , identical to those in MDCK cells, indicating that a pathway corresponding to the basolateral route in MDCK cells exists in 3T3 fibroblasts and has a similar transport capacity as in the epithelial cell line. The release of H A from the TGN of 3T3 cells was inhibited by the VSVG peptide with a IC-50 of 60 p~M (Fig. 4, Table III ). This represents an inhibitory potency 3 x lower than for VSVG, suggesting that a population of H A molecules is transported via a peptide-insensitive pathway. Fig. 4 , however, also shows that the peptide inhibited the release of H A protein in 3T3 ceils with a 2.5 x higher inhibitory potency than in MDCK cells. Furthermore, whereas 50 ~M VSVGp caused no inhibition of H A budding in the presence of 3 txl cytosol, the same peptide concentration reduced H A budding in 3T3 cells by N50%, even in the presence of 6 ~1 cytosol in the budding assay. Higher cytosol concentrations, however, were effective in overcoming the effect of 50 ~M peptide in this cell line as expected for an interaction between the peptide and a cytosolic factor (data not shown). The observation that the inhibitory potency of the VSVG peptide on the release of H A protein in 3T3 ceils was intermediate between its poor inhibitory potency on HA protein budding in MDCK cells and its powerful effect on VSVG protein release in both cell lines suggests that an apical-like pathway exists in 3T3 fibroblasts, albeit with a lower capacity than in MDCK cells.
Budding of VSVG-containing Vesicles and Nascent Secretory Granules in Permeabilized GH3 Cells
Earlier work (Green and Shields, 1984) suggested that G H and VSVG protein are sorted into different vesicle populations in VSV-infected GH3 cells. This sorting step was presumed to occur late in the secretory pathway because inhibition of G H secretion had no effect on the appear- ance of VSVG protein at the plasma membrane or on virus assembly. Based on the preceding data and these earlier observations, we hypothesized that the VSVG peptide would interfere with VSVG protein vesicle budding, but would have little effect on the formation of GH-or Prlcontaining secretory vesicles. To test this idea, we prepared permeabilized cells from VSV-infected GH3 cells (Xu and Shields, 1993) and added either VSVG peptide or the VSVGA19 control peptide to the in vitro budding system (Fig. 8) . Consistent with our earlier observations, vesicle budding from the TGN was energy and cytosol dependent ( Fig. 8 A, compare lanes 12 and 13 with 25 and 26).
Addition of the VSVG peptide to the permeabilized cells inhibited vesicle budding fourfold at a concentration of 20-30 txM (Fig. 5 A, lanes 3, 4,16 and 17; D) . In agreement with the preceding data on MDCK cells, the mutant VSVG A19 peptide had no effect on vesicle formation even up 150 /zM (Fig. 8 A , lanes 7-12 and 20-24; D) . In contrast, addition of the VSVG peptide had no effect on the budding of either GH-or Prl-containing nascent vesicles ( Fig. 8 B and C, respectively, Fig. 6 E) . It should be noted that in B and C, the permeabilized cell system was prepared from uninfected cells because VSV infection completely inhibits endogenous G H and Prl synthesis and in this case vesicle budding did not require addition of cytosol.
In agreement with our earlier observations, these results strongly suggest that VSVG protein is packaged into a different population of vesicles from those containing either G H or Prl. Most significantly, the current data imply that the host cell "target" molecules that interact with the cytoplasmic tail of VSVG protein to effect its packaging into vesicles, can be inhibited without affecting formation of nascent secretory granules.
D i s c u s s i o n
A main goal of this work was to study the requirement of basolateral sorting signals in the constitutive transport of VSVG protein to the surface of polarized and nonpolarized cells. Basolateral sorting signals have been identified unequivocally in the cytoplasmic domain of a variety of basolateral proteins (Matter and Mellman, 1994) , but their role in anterograde transport is not well understood. We wished to determine whether (a) nonpolarized cells require signals to transport basolateral proteins from the TGN to the cell surface or, alternatively, use a default mechanism, as widely believed (Alberts et al., 1994); basolateral signals act by concentrating and sorting basolateral proteins into nascent basolateral vesicles or by promoting the assembly of the basolateral vesicles themselves; (c) cytoplasmic signals are required to segregate VSVG protein from regulated secretory proteins. To this end we used different permeabilized cells, incubated in the presence and absence of basolateral signal peptides, and compared the release of the VSVG protein from the TGN with that of several proteins whose intracellular transport is diagnostic for different vesicle populations (Figs. 4 and 8, Table III ). 
Transport of VSVG Protein Requires a Cytoplasmic Signal in Nonpolarized Cells
The requirement for signals in anterograde transport from the TGN might have evolved in epithelial cells as a consequence of their need to target proteins to two different surface domains. If so, it might be expected that a basolateral signal peptide would not inhibit transport of a basolateral protein in nonpolarized cells, where proteins would follow a bulk flow pathway to the cell surface. However, the VSVG peptide inhibited the release of VSVG with the same potency in 3T3 cells as in MDCK cells , indicating that VSVG, a prototype marker for bulk flow studies (Moore and Kelly, 1985; Orci et al., 1986; Wieland et al., 1987) requires cytoplasmic signals to exit the TGN of nonpolarized and polarized cells (Fig. 4) . The strict signal dependence of VSVG tranport in nonpolarized cells suggests that proteins not possessing these signals, e.g., apical proteins, might use a separate transport mechanism, equivalent to the apical transport pathway of epithelial cells. Since the release of influenza HA from the TGN of MDCK cells could be distinguished by its 6 × lower sensitivity to VSVGp (IC-50 ~145 ~M) we tested the effect of VSVGp on the release of influenza HA in 3T3 fibroblasts. We found that VSVGp inhibited release of the apical marker HA in 3T3 fibroblasts with an intermediate potency (apparent IC-50 ~60 txM) between VSVG (20 I~M) and HA (IC-50 ~145 ixM) in MDCK cells. Because the budding of HA vesicles is more sensitive to VSVG peptide in 3T3 cells than in MDCK cells, we suggest that the machinery to generate apical vesicles may be present but not fully developed in these nonpolarized flbroblasts. In fact, the capacity of the apical transport pathway appears to be highly variable even in epithelial cells; in intestinal cells it appears to be underdeveloped, whereas it is absent in hepatocytes (for reviews see Rodriguez-Boulan and Powell, 1992; Matter and Mellman, 1994) .
Role of Basolateral Signals in the Assembly of Basolateral Vesicles
Our in vitro data do not support the bulk flow model of protein transport to the plasma membrane, which suggests that Golgi-derived transport vesicles are constantly formed independently of the presence or absence of signals in the cargo protein. In our experiments, the VSVG protein is the major cargo protein in the TGN because host cell protein synthesis was inhibited by viral infection. The complete inhibition of VSVG release by VSVGp suggests that VSVG cannot be transported by an alternative apical route in the absence of apical cargo proteins. This contrasts starkly with the in vivo observation in transfected cells, that VSVG protein is missorted but not blocked by the inactivation of its basolateral signal by mutagenesis (Rose and Bergmann, 1983; Gonzalez et al., 1987; Thomas et al., 1993) . In fact, the observation that VSVGp is twofold less efficient in inhibiting the release of TGG-containing vesicles in noninfected cells could be also explained by the existence of an apical transport pathway in these cells. Our results lead us to conclude that (a) the release of basolateral proteins in transport vesicles requires the interaction of cargo protein sorting signals in the TGN with a component of the transport machinery in the TGN and hence does not occur by bulk flow, and (b) apical vesicles or mock-infected (B and C) permeabilized GH3 cells were incubated with cytosol and energy mix to release TGN-derived vesicles. VSVG peptide or the control peptide VSVGA19 was incubated at the indicated concentrations with the cytosol in budding reaction; both, the vesicle fraction (SUPERNATANT) and the semi-intact cells (PELLET) were immunoprecipitated with anti-VSVG (A), anti-GH (B), or anti-Prl (C) antibodies; -CYTOSOL and -ENERGY indicate that either cytosol or the energy-regenerating system was omitted in the assay. (D and E) The intensities of each band were quantitated using a computing densitometer (300A; Molecular Dynamics Inc., Sunnyvale, CA). Budding efficiency (percent budding) = (sum of the band intensities from the supernatant [vesicle fraction]) -(sum of the band intensities from the pellet and supernatant) × I00.
are not released by bulk flow, since a basolateral protein can be missorted into apical vesicles only when apical cargo proteins are present in the TGN but not in their absence. A corollary is that basolateral proteins can use an existing apical pathway but cannot create one.
Our experimental conditions did not allow us to test directly whether the cytoplasmic domain of VSVG protein is necessary just to concentrate VSVG into post-TGN transport vesicles or, alternatively, is necessary for the assembly of the vesicles. In the first scenario, addition of VSVG peptide would result in the production of "empty" transport vesicles, whereas in the second scenario no post-TGN basolateral vesicles would be formed in the presence of VSVGp. We favor the second possibility based on the in vivo data described above. 50-67% VSVG protein carrying an inactivated basolateral sorting signal is transported efficiently to the basolateral surface of transfected MDCK cells (Gonzalez et al., 1987; Thomas et al., 1993) , where other basolateral proteins are synthesized and delivered to the cell surface, suggesting that VSVG protein is included in basolateral transport vesicles as long as other basolateral proteins promote the assembly of these vesicles. Hence, lack of sorting can not result in complete inhibition of transport. Rather, the complete inhibition of transport observed in infected cells exposed to VSVG peptide (Pimplikar and Simons, 1994 ; and this paper) most likely reflects the complete inhibition of vesicle release from the TGN.
A surprising outcome of our study was the similar inhibitory potency of the basolateral sorting peptides H A Y p and TGN38p on the release of basolateral and apical vesicles in MDCK cells. We suggest that this effect is due to the basolateral signal content in both peptides for two reasons: (a) the control H A C peptide (the normal cytoplasmic domain of influenza H A which has no activity as a basolateral signal), did not inhibit the budding of either marker; (b) none of the other tested nonsignal peptides inhibited the release of either marker at similar concentrations. Recent evidence indicates that signals for coated pit, TGN, and lysosomal localization share structural features with basolateral signals (Thomas and Roth, 1994) . The short peptides HAYp and TGN38p could represent degenerate signals sufficient to be recognized by both apical and basolateral soluble binding factors; only the VSVG peptide, with 29 amino acids by far the longest peptide tested, could meet the requirements for a basolateral sorting sequence strictly, resulting in a six times higher inhibitory potency for basolateral vesicles (IC50 ,-~24 IxM) than for apical vesicles (IC50 ,-~145 ~M). These results further suggest that the exit of apical proteins from the TGN of MDCK cells also requires specific cytoplasmic factors. Since apical membrane proteins do not seem to contain cytoplasmic targeting information, or simply lack cytoplasmic domains, the signal for assembly of apical vesicles would be contained in a transmembrane apical sorting receptor. This receptor could function as an adaptor by interacting with apical markers via its luminal domain and with the vesicle assembly machinery via its cytoplasmic domain. Alternatively, HAYp and TGN38p could bind a different soluble budding factor than VSVGp, one that is involved in the production of both apical and basolateral vesicles.
An unexpected observation was that two basolateral signal peptides, LEP100p and pIgRp, did not inhibit the release of the basolateral marker VSVG. Two possible scenarios can be envisioned that would explain this observation. An interesting possibility is that their failure to inhibit the release of VSVG-containing vesicles from the TGN may reflect the use of alternate basolateral targeting mechanisms by plgA-R and LEP-100. In fact, in contrast to VSVG, plgA-R is rapidly endocytosed and undergoes a second sorting event in basolateral endosomes (Aroeti and Mostov, 1994) . Furthermore, pharmacological studies using brefeldin A have suggested that plgA-R might use a pathway to the plasma membrane different from other basolateral proteins (Apodaca et al., 1993 ). An alternative trivial explanation of the data is that the plgA-R and LEP-100 peptides fail to adopt the competent secondary structure they have in the context of the protein from which they are derived. However, the plgA-R peptide functions as a basolateral sorting signal when transferred to other proteins (Casanova et al., 1991) and alters its secondary structure in solution when signal-disabling mutations are introduced, as determined by NMR analysis , suggesting that it may preserve basolateral signal activity in solution.
Cytoplasmic Signals Are Required to Segregate VSVG Protein from Regulated Secretory Proteins
Experiments with VSV-infected GH3 pituitary cells showed that, in regulated secretory cells, constitutive release of VSVG protein from the TGN does not occur by default, but is strictly dependent on signal information in the cytoplasmic domain. The release of VSVG protein was inhibited by VSVG peptide with the same potency as in MDCK cells and 3T3 fibroblasts. In contrast, the release of GH and Prl was not affected by VSVGp. This latter result was surprising since in vivo experiments indicate that 70-80% of these two regulated secretory proteins are released constitutively in GH3 cells (Stoller and Shields, 1988) . Two different scenarios may account for this observation. In the first scenario, the block of the major constitutive route by the VSVG peptide leads to more efficient packaging of the constitutively secreted fraction of GH and Prl into immature secretory granules (Fig. 9 ). In the second scenario, GH and Prl are transported via a secondary constitutive pathway to the cell surface that is insensitive to VSVGp, perhaps the equivalent of the apical pathway of epithelial cells. In fact, Orci et al. (1987a) have shown that HA is transported through a pathway distinct from the regulated secretory route in neuroendocrine cells.
In summary, the results presented in this report support a model in which VSVG protein is transported by the same signal-mediated mechanism in polarized and nonpolarized cells (Fig. 9) . The requirement for signals excludes bulk flow as a mechanism for constitutive transport of proteins between the TGN and the cell surface in all cells. It also predicts the existence of cytosolic factors that interact with the basolateral-like signals in the cytoplasmic domain of the transported proteins. Our data also suggest the existence of an alternative apical-like pathway in 3T3 fibroblasts that is, however, considerably less developed than in MDCK cells and the existence of a basolateral signal independent pathway to the plasma membrane of GH3 cells. Thus, the existence of more than one pathway to the cell surface appears to be a widely distributed property of mammalian cells.
